Judit Boda‐Heggemann

ORCID: 0000-0002-5831-0197
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Medical Imaging Techniques and Applications
  • Lung Cancer Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Radiation Therapy and Dosimetry
  • Cardiac Arrhythmias and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Radiation Dose and Imaging
  • Cardiac electrophysiology and arrhythmias
  • Advanced X-ray and CT Imaging
  • Cardiac pacing and defibrillation studies
  • Advanced MRI Techniques and Applications
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • MRI in cancer diagnosis
  • Management of metastatic bone disease
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Radiopharmaceutical Chemistry and Applications
  • Atrial Fibrillation Management and Outcomes
  • Wnt/β-catenin signaling in development and cancer
  • Renal cell carcinoma treatment
  • Glioma Diagnosis and Treatment
  • Colorectal Cancer Surgical Treatments
  • Pancreatic and Hepatic Oncology Research
  • Metastasis and carcinoma case studies

Klinik und Poliklinik für Strahlentherapie und Radioonkologie
2006-2025

Heidelberg University
2016-2025

University Hospital Heidelberg
2016-2025

University Medical Centre Mannheim
2016-2025

Medizinische Fakultät Mannheim
2012-2023

University of Mannheim
2010-2023

University Medical Center Freiburg
2018

University Hospital Schleswig-Holstein
2017

University of Lübeck
2017

Universitätsklinik für Strahlentherapie
2013

The intent of this pooled analysis as part the German society for radiation oncology (DEGRO) stereotactic body radiotherapy (SBRT) initiative was to analyze patterns care SBRT liver oligometastases and derive factors influencing treated metastases control overall survival in a large patient cohort. From 17 Swiss centers, data on all patients with since its introduction 1997 has been collected entered into centralized database. In addition tumor characteristics, immobilization, image guidance...

10.1186/s12885-018-4191-2 article EN cc-by BMC Cancer 2018-03-13

The aim of this analysis was to model the effect local control (LC) on overall survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung metastases from colorectal cancer.The is based pooled data two retrospective SBRT databases pulmonary and hepatic 27 centers Germany Switzerland. Only cancer were considered avoid histology as a confounding factor. An illness-death employed relationship between LC OS.Three hundred eighty-eight 500 metastatic lesions...

10.1186/s12885-019-5362-5 article EN cc-by BMC Cancer 2019-02-26

Abstract Background Single-session high-dose stereotactic radiotherapy (radiosurgery) is a new treatment option for otherwise untreatable patients suffering from refractory ventricular tachycardia (VT). In the initial single-center case studies and feasibility trials, cardiac radiosurgery has led to significant reductions of VT burden with limited toxicities. However, full safety profile remains largely unknown. Methods/design this multi-center, multi-platform clinical trial which we plan...

10.1007/s00392-020-01650-9 article EN cc-by Clinical Research in Cardiology 2020-04-18

To develop expert consensus statements on multiparametric dose prescriptions for stereotactic body radiotherapy (SBRT) aligning with ICRU report 91. These serve as a foundational step towards harmonizing current SBRT practices and refining prescription documentation requirements clinical trial designs.

10.1007/s00066-024-02254-2 article EN cc-by Strahlentherapie und Onkologie 2024-07-12

Renal cell carcinoma (RCC) is traditionally considered to be radioresistant. Radiotherapy response rates are believed improve with hypofractionated, high dose stereotactic body radiotherapy (SBRT). However, limited data exist regarding the role of SBRT in treatment pulmonary metastases.The working group "Stereotactic Radiotherapy" German Society Radiation Oncology analyzed its multi-institutional database more than 700 patients who received for metastases. Treatment was performed at 10...

10.21037/jtd.2017.10.108 article EN cc-by-nc-nd Journal of Thoracic Disease 2017-11-01

Ventricular tachycardia (VT) is a potentially lethal complication of structural heart disease. Despite optimal management, subgroup patients continue to suffer from recurrent VT. Recently, cardiac stereotactic body radiotherapy (CSBRT) has been introduced as treatment option in with VT refractory antiarrhythmic drugs and catheter ablation.The purpose this study was establish an expert consensus regarding the conduct use CSBRT for VT.We conducted modified Delphi process. Thirteen experts...

10.1016/j.hrthm.2021.08.004 article EN cc-by Heart Rhythm 2021-08-08

Single-session cardiac stereotactic radiation therapy (SBRT) has demonstrated promising results for patients with refractory ventricular tachycardia (VT). However, the full safety profile of this novel treatment remains unknown and very limited data from prospective clinical multicenter trials are available.The multiplatform RAVENTA (radiosurgery tachycardia) study assesses high-precision image-guided SBRT 25 Gy delivered to VT substrate determined by high-definition endocardial and/or...

10.1007/s00066-023-02091-9 article EN cc-by Strahlentherapie und Onkologie 2023-06-07

Inhalt Seite Wesentliche Neuerungen e84 1 Informationen zu dieser Leitlinie e85 1.1 Herausgeber 1.2 Federführende Fachgesellschaft(en) 1.3 Finanzierung der 1.4 Kontakt 1.5 Zitierweise 1.6 Besonderer Hinweis 1.7 Ziele des Leitlinienprogramms Onkologie 1.8 Weitere Dokumente e86 1.9 Zusammensetzung Leitliniengruppe 1.9.1 Koordination 1.9.2 Beteiligte Fachgesellschaften und Organisationen 1.9.3 Arbeitsgruppen e88 1.9.4 Patientenbeteiligung 1.9.5 Methodische Begleitung 1.10 Abkürzungsverzeichnis...

10.1055/a-2460-6347 article DE Zeitschrift für Gastroenterologie 2025-02-01

Substrate-adherent cultured cells derived from human bone marrow or umbilical cord blood ("mesenchymal stem cells") are of special interest for regenerative medicine. We report that such cells, which can display considerable heterogeneity with respect to their cytoskeletal protein complement, often interconnected by tentacle-like cell processes contacting one several other cells. These processus adhaerentes, studded many (usually small) puncta adhaerentia and varying greatly in length (up...

10.1007/s00441-007-0379-5 article EN cc-by-nc Cell and Tissue Research 2007-03-19
Coming Soon ...